Skip to content

Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases

Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04283903
Enrollment
25
Registered
2020-02-25
Start date
2019-05-01
Completion date
2025-05-01
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis, Peri-implant Mucositis

Brief summary

Due to the limited efficacy of its treatment modalities, there is a stringent need to improve the prevention and early diagnosis of peri-implantitis. In fact, to date clinical and radiographic tools are not able to discern which patients are going to develop peri-implantitis and, among the ones already with peri-implantitis, which ones are currently loosing bone and which ones are going to progress. This project aims to analyze for the first time the whole large scale proteome and metabolome of peri-implant crevicular fluid (PICF) with an integrated approach from implants with peri-implant diseases. Twenty-five patients with at least one implant with peri-implant mucositis and one implant with peri-implantitis will be selected. For each of the selected participants, the PICF from an implant with peri-implant mucositis and from an implant with peri-implantitis will be sampled two different times before treatment. One year after the corresponding treatment is provided, the PICF of the treated implants with peri-implantitis will be sampled again. Both proteomic and metabolomic profiling of the samples will be carried out. The most important strength of this project will be the ability to evaluate together the whole proteome and the whole metabolome and to integrate them in the same framework.

Interventions

DIAGNOSTIC_TESTPICF

PICF collection from 4 sites

Sponsors

Universidad Complutense de Madrid
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* At least one implant with peri-implant mucositis and one with peri-implantitis

Exclusion criteria

* Previously treated implants to be included

Design outcomes

Primary

MeasureTime frameDescription
Peri-implant diseases presenceBaseline (cross-sectional part)Presence or absence of peri-implant mucositis or peri-implantitis according to the 2017 World Workshop (Berglundh et al. 2018)
Disease resolution of peri-implantitis1-year after treatment (longitudinal part)According to the criteria proposed by Sanz & Chapple (2012)

Countries

Spain

Contacts

Primary ContactMario Romandini
maromand@ucm.es+393801563046

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026